Boston Scientific Raises Outlook on Continued Cardiovascular Growth

The medical device company recorded higher third-quarter sales and raised its full-year earnings guidance on the back of ...

Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum

Q3 2025 Management View CEO Michael Mahoney reported, “In third quarter '25, total company operational sales grew 19% and organic sales grew 15%, exceeding the high end of our guidance range of 12% to ...

New Boston Scientific facility opens

Boston Scientific held a ribbon cutting for a new biotech facility in Maple Grove on Monday. Leaders at Boston Scientific say ...

5 Nobel-worthy scientific advances that haven’t won the prize

Innovative obesity drugs. Quantum computing bits. A cystic fibrosis treatment. The scientists behind these discoveries could ...

Thermo Fisher Scientific Inc (TMO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Thermo Fisher Scientific Inc (TMO) reports robust financial performance with a 5% revenue increase and upwardly revised 2025 ...